2021 CRO Leadership Awards - Winners Lists

Based on research from ISR’s Contract Research Organization Quality Benchmarking annual online surveys, nearly 60 contract research organizations were evaluated on 23 different performance metrics. Respondents only evaluated companies with which they have worked on an outsourced project in the past 18 months.

Respondents answered questions on outsourcing practices and preferences and rated CROs across 23 performance attributes. Points were then totaled for a combined score for each attribute, and a composite score for each core category was determined. Winning CROs were identified when comparing their overall score vs. the competitive set. CROs have an opportunity to win these awards in up to three groups of outsourcing respondents — Big Pharma, Small Pharma, and Overall (combined Big and Small Pharma).

The main attributes for consideration of a CRO Leadership Award in CAPABILITIES are:

  • Access to patient populations
  • Access to "unique" tests, machines, equipment
  • Biostatistics
  • Central lab
  • Data management
  • Investigator recruitment
  • Monitoring
  • Patient recruitment (Phase II/III)
  • Patient/volunteer recruitment (Phase I)
  • Speed of site start-up
  • Technology for real-time access to data

EXCEEDED CUSTOMER EXPECTATIONS

OVERALL BIG PHARMA SMALL PHARMA
  • Innovaderm
  • CTI Clinical Trial & Consulting
  • Ora
  • PSI CRO
  • Celerion
  • Quotient Sciences
  • Worldwide Clinical Trials
  • Eurofins Scientific, S.E.
  • Frontage Laboratories, Inc.
  • Parexel
  • Bioclinica
  • IQVIA
  • Worldwide Clinical Trials
  • Celerion
  • Frontage Laboratories, Inc.
  • ICON plc
  • Parexel
  • Celerion
  • PSI CRO
  • Ora
  • Worldwide Clinical Trials
  • Quotient Sciences
  • QPS LLC
  • Bioclinica
  • Medpace
  • Covance by Labcorp
  • IQVIA
  • PPD
  • Duke Clinical Research Institute
  • Eurofins Scientific, S.E.
  • Parexel
  • PRA Health Sciences

 

The main attributes for consideration of a CRO Leadership Award in COMPATIBILITY are:

  • Easy to work with
  • Responsiveness
  • Timely project communications

CHAMPIONS - companies that scored 1½ standard deviation or more above the weighted average

OVERALL BIG PHARMA SMALL PHARMA
  • CTI Clinical Trial & Consulting Services
   

 

EXCEEDED CUSTOMER EXPECTATIONS

OVERALL BIG PHARMA SMALL PHARMA
  • Quotient Sciences
  • PSI CRO
  • Celerion
  • Innovaderm
  • Frontage Laboratories, Inc.
  • QPS LLC
  • Worldwide Clinical Trials
  • Medpace
  • Eurofins Scientific, S.E.
  • ICON plc
  • Duke Clinical Research Institute
  • SGS Health Science
  • Syneos Health
  • Celerion
  • Frontage Laboratories, Inc.
  • SGS Health Science
  • ICON plc
  • Eurofins Scientific, S.E.
  • Syneos Health
  • Worldwide Clinical Trials
  • PSI CRO
  • Quotient Sciences
  • Celerion
  • Worldwide Clinical Trials
  • QPS LLC
  • Frontage Laboratories, Inc.
  • Duke Clinical Research Institute
  • Medpace
  • Bioclinica
  • Novotech
  • PPD

 

The main attributes for consideration of a CRO Leadership Award in EXPERTISE are:

  • Local market/Regulatory knowledge
  • Operational excellence
  • Scientific knowledge of the Phase I unit's lead investigator
  • Study design expertise
  • Therapeutic expertise

CHAMPIONS - companies that scored 1½ standard deviation or more above the weighted average

OVERALL BIG PHARMA SMALL PHARMA
  • PSI CRO
  • Quotient Sciences
 
  • PSI CRO

 

EXCEEDED CUSTOMER EXPECTATIONS

OVERALL BIG PHARMA SMALL PHARMA
  • Innovaderm
  • CTI Clinical Trial & Consulting
  • Ora
  • Celerions
  • Duke Clinical Research Institut
  • Worldwide Clinical Trials
  • Eurofins Scientific, S.E
  • Frontage Laboratories, Inc.
  • Parexel
  • QPS LLC
  • Medpace
  • Eurofins Scientific, S.E.
  • Celerion
  • Frontage Laboratories, Inc.
  • ICON plc
  • Parexel
  • Worldwide Clinical Trials
  • Quotient Sciences
  • Ora
  • Celerion
  • Medpace
  • Worldwide Clinical Trials
  • Duke Clinical Research Institute
  • Frontage Laboratories, Inc.
  • QPS LLC
  • Bioclinica
  • Eurofins Scientific, S.E.
  • Syneos Health
  • IQVIA
  • Covance by Labcorp

 

 

The main attributes for consideration of a CRO Leadership Award in QUALITY are:

  • Data quality
  • Project manager

CHAMPIONS - companies that scored 1½ standard deviation or more above the weighted average

OVERALL BIG PHARMA SMALL PHARMA
  • Quotient Sciences
   

 

EXCEEDED CUSTOMER EXPECTATIONS

OVERALL BIG PHARMA SMALL PHARMA
  • PSI CRO
  • CTI Clinical Trial & Consulting
  • Celerion
  • Innovaderm
  • Worldwide Clinical Trials
  • Duke Clinical Research Institute
  • Frontage Laboratories, Inc.
  • ICON plc
  • Parexel
  • Eurofins Scientific, S.E.
  • Celerion
  • Eurofins Scientific, S.E.
  • ICON plc
  • Worldwide Clinical Trials
  • Parexel
  • SGS Health Science
  • Quotient Sciences
  • PSI CRO
  • Celerion
  • Frontage Laboratories, Inc.
  • QPS LLC
  • Duke Clinical Research Institute
  • Medpace
  • Worldwide Clinical Trials
  • PRA Health Sciences

 

The main attributes for consideration of a CRO Leadership Award in RELIABILITY are:

  • Meeting overall project timelines
  • Operational Excellence
  • Staff Turnover

EXCEEDED CUSTOMER EXPECTATIONS

OVERALL BIG PHARMA SMALL PHARMA
  • PSI CRO
  • CTI Clinical Trial & Consulting
  • Quotient Sciences
  • Innovaderm
  • Celerion
  • Ora
  • Frontage Laboratories, Inc.
  • Worldwide Clinical Trials
  • SGS Health Science
  • Duke Clinical Research Institute
  • QPS LLC
  • Eurofins Scientific, S.E.
  • Medpace
  • Parexel
  • PRA Health Sciences
  • Celerion
  • Eurofins Scientific, S.E.
  • SGS Health Science
  • Frontage Laboratories, Inc.
  • ICON plc
  • Parexel
  • PSI CRO
  • Quotient Sciences
  • Celerion
  • Worldwide Clinical Trials
  • Medpace
  • Ora
  • QPS LLC
  • Duke Clinical Research Institute
  • Bioclinica
  • PRA Health Sciences
  • Frontage Laboratories, Inc.